Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease

Transplantation

Volumn 81, Issue 10, 2006, Pages 1410-1414

  Westhoff, Timm H ^a   Straub Hohenbleicher, Henriette ^a   Basdorf, Matthias ^a   Van Der Giet, Simone ^a   Schmidt, Sven ^a   Offermann, Gerd ^a   Schlattmann, Peter ^a   Zidek, Walter ^a   Van Der Giet, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; CIRCULATION; CLINICAL ARTICLE; ELASTICITY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; ARTERIES; CADAVER; COMPLIANCE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 33744943520     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000209418.67546.63     Document Type: Article

References (29)

1. Blacher J, Pannier B, Guerin AP, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32(3): 570.
2. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99(18): 2434.
3. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38(4): 938.
4. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004; 43(2): 163.
5. Barenbrock M, Spieker C, Laske V, et al. Effect of long-term hemodialysis on arterial compliance in end-stage renal failure. Nephron 1993; 65(2): 249.
6. London GM, Guerin AP, Pannier B, et al. Large artery structure and function in hypertension and end-stage renal disease. J Hypertens 1998; 16(12 Pt 2):1931.
7. London GM, Guerin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50(2): 600.
8. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87(7): E10.
9. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003; 76(11): 1573.
10. Zoungas S, Kerr PG, Chadban S, et al. Arterial function after successful renal transplantation. Kidney Int 2004; 65(5): 1882.
11. Cohn JN, Finkelstein S, McVeigh G, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26(3): 503.
12. Garg JP, Ellis R, Elliott WJ, et al. Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study. Am J Nephrol 2005; 25(4): 393.
13. Cohen DL, Warburton KM, Warren G, et al. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients. Am J Hypertens 2004; 17(3): 209.
14. Grey E, Bratteli C, Glasser SP, et al. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 2003; 16(4): 265.
15. Guyton AC, Hall JE. Human Physiology and Mechanisms of Disease. 6th ed. Philadelphia: Saunders, 1997.
16. Annuk M, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int Suppl 2003 (84): S50.
17. Vanholder R, Glorieux G, Lameire N. New insights in uremic toxicity. Contrib Nephrol 2005; 149: 315.
18. Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol 2005; 63(2): 146.
19. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95(6): 560.
20. Jankowski J, van der Giet M, Jankowski V, et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 2003; 112(2): 256.
21. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361(9360): 827.
22. Simmons EM, Langone A, Sezer MT, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005; 79(8): 914.
23. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993; 91(5): 2144.
24. De Nicola L, Thomson SC, Wead LM, et al. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92(4): 1859.
25. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43(3): 706.
26. Wolf A, Trendelenburg CF, Diez-Fernandez C, et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997; 280(3): 1328.
27. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990; 323(11): 693.
28. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341(23): 1725.
29. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2005.